By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ViaCell, Inc. 

245 First Street
15th Floor
Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-914-3400 Fax: 617-577-9010


SEARCH JOBS

ViaCell is a biotechnology company dedicated to enabling the widespread application of human cells as medicine.

The Company markets ViaCord(R), a product offering through which families can preserve their baby’s umbilical cord blood at the time of birth for possible future medical use in treating over 40 diseases including certain blood cancers and genetic diseases.ViaCell also conducts research and development primarily to investigate other potential therapeutic uses of umbilical cord blood-derived stem cells and on technology for expanding populations of these cells.

ViaCell’s pipeline is focused in the areas of cancer, cardiac disease, diabetes and fertility.

In March 2007, ViaCell commenced a pivotal clinical trial evaluating ViaCyte, an investigational product being studied for the cryopreservation and thawing of human oocytes for use during assisted reproductive technology.

ViaCell is headquartered in Cambridge, Massachusetts with a processing and storage facility in Hebron, Kentucky.

Key Statistics


Email: info@viacellinc.com
Ownership: Public

Web Site: ViaCell
Employees: 265
Symbol: VIAC
 



Industry
Biotechnology






Company News
PerkinElmer, Inc. (PKI) Completes Acquisition of ViaCell, Inc. (VIAC) 11/15/2007 9:03:28 AM
ViaCell, Inc. (VIAC) Reports Third Quarter 2007 Financial Results 11/9/2007 10:47:19 AM
PerkinElmer, Inc. (PKI) Announces Expiration of Hart-Scott-Rodino Waiting Period of Proposed ViaCell, Inc. (VIAC) Acquisition 10/25/2007 8:53:48 AM
PerkinElmer, Inc. (PKI) Commences Cash Tender Offer for ViaCell, Inc. (VIAC) 10/12/2007 9:02:59 AM
PerkinElmer, Inc. (PKI) (Jobs) to Expand Genetic Screening Business Through Acquisition of ViaCell, Inc. (VIAC); Approximately $300 Million 10/1/2007 11:10:36 PM
Children Can be Cured of Sickle Cell Disease and Thalassemia After Sibling Cord Blood Transplantation: Results from ViaCell, Inc. (VIAC) and Children's Hospital & Research Center At Oakland 9/20/2007 9:19:51 AM
ViaCell, Inc. (VIAC) Announces Expansion of ViaCord Processing Laboratory 9/18/2007 11:53:49 AM
ViaCell, Inc. (VIAC) to Present at the 2007 UBS Warburg Global Life Sciences Conference 9/18/2007 11:53:08 AM
ViaCell, Inc. (VIAC) Announces ViaCyte Collaboration with EMD Serono 9/4/2007 11:40:55 AM
ViaCell, Inc. (VIAC) Expands Study Sites in ViaCyte Pivotal Trial 8/22/2007 8:07:04 AM
12345678910
//-->